| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 3e-05 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 4.7e-06 | 1 |